These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5911139)

  • 1. The use of bismuth subnitrate in the treatment of dyspepsias of various origin.
    Pinter EJ
    Appl Ther; 1966 Jul; 8(7):630-2. PubMed ID: 5911139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bismuth subnitrate in the treatment of dyspepsia of diverse etiology].
    Pinter EJ
    Union Med Can; 1965 Dec; 94(12):1663-5. PubMed ID: 5851655
    [No Abstract]   [Full Text] [Related]  

  • 3. Further experience with bismuth aluminate in peptic ulceration and nervous dyspepsia.
    Matts SG
    Br J Clin Pract; 1965 Oct; 19(10):569-71. PubMed ID: 5830345
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bismuth subnitrate in the treatment of gastrointestinal disorders].
    Thibert F
    Union Med Can; 1965 Dec; 94(12):1660-2. PubMed ID: 5851654
    [No Abstract]   [Full Text] [Related]  

  • 5. [Importance of a new polymetallic silicic derivative (bismuth-magnesium-sodium alumino-silicate) in the treatment of common intestinal dyspepsia of the newborn].
    Combes-Hamelle A; Frot R
    Ann Pediatr (Paris); 1967 Oct; 14(10):2482-3. PubMed ID: 5621840
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bismuth from the past. A future alternative in the treatment of dyspeptic disorders?].
    O'Leary D; Husebye E; Osnes M; Melby K
    Tidsskr Nor Laegeforen; 1988 Sep; 108(25):2042-3. PubMed ID: 3059560
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of 2 treatment schemes to eradicate Helicobacter pylori].
    Hoffenberg P; Reyes V; Contreras L; Giglio M; Ossa P; Weitz JC
    Rev Med Chil; 1995 Feb; 123(2):185-91. PubMed ID: 7569458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new mode of using bismuth in gastroenterology. Report on experimentation in 49 cases].
    Poirier JP
    Therapeutique; 1970 Mar; 46(3):303-5. PubMed ID: 5422198
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of dyspepsias with a poly-enzymatic drug].
    Warembourg H; Delbecque H
    Lille Med; 1967 Nov; 12(9):Suppl:1146-51. PubMed ID: 4912674
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
    J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Helicobacter pylori eradication therapy with bismuth citrate/amoxycillin combination therapy].
    Stanescu A; Mayer D; Gabard B; Jost G; Baczako K; Dragici A; Malfertheiner P
    Leber Magen Darm; 1996 Jan; 26(1):32-6. PubMed ID: 8851875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations with dopamine antagonist domperidone (Motilium) in controlling postoperative dyspepsias and vomiting.
    Horváth I
    Ther Hung; 1987; 35(2):89-93. PubMed ID: 3438869
    [No Abstract]   [Full Text] [Related]  

  • 14. [Substitution therapy in digestive insufficiency following subtotal gastrectomy and dyspepsias of other genesis].
    Preisich P; Farkas I
    Z Allgemeinmed; 1971 Nov; 47(33):1768-70. PubMed ID: 5131395
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
    Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
    Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori infection and non-ulcer dyspepsia].
    Malfertheiner P
    Bildgebung; 1995 Apr; 62 Suppl 1():66-9. PubMed ID: 7670310
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of constipation and colitis by the bismuth subnitrate--karaya gum association].
    Gisselbrecht H; Monange C; Clement D
    Lyon Med; 1970 May; 223(18):951-8. PubMed ID: 5425997
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-ulcer dyspepsia and Helicobacter pylori infection--morphological analysis according to the Sydney system--changes before and after treatment.
    Lewy-Trenda I; Trenda P; Wierzchniewska A
    Pol J Pathol; 1996; 47(2):57-63. PubMed ID: 8854727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.